Prof Peter R Schofield

Personal information

Name

Prof Peter R Schofield

Phone number

+612 9399 1004

Executive profile

Executive position

Executive Director and Chief Executive Officer, 2004 - present

Member, Building Committee, 2008 - present

Member, Nomination Committee, 2010 - present

Chairman, Investment Committee, 2010 - present

Qualifications

BScAgr(Hons) PhD DSc

Leadership bio

Researcher profile

Current appointments

Executive Director and Chief Executive Officer, Neuroscience Research Australia

Professor, School of Medicine, University of New South Wales

Bio

Appointed Institute head in 2004, Peter graduated from the University of Sydney with the University Medal and was awarded a PhD in genetics from The Australian National University in 1985. He undertook postdoctoral positions in biotechnology in the US and the University of Heidelberg. Peter was appointed a NHMRC Senior Research Fellow at the Garvan Institute in 1993, becoming head of the Neurobiology Research Program in 1999. His research interests focus on identifying genes that lead to mental illness and to dementia.

Prizes and Awards:

• 1982 - The University Medal, Faculty of Agriculture, University of Sydney
• 1990 - A.W. Campbell Award, Australian Neuroscience Society
• 1991 - Elsie Waltham Thompson Award, National Heart Foundation
• 1995 - Boehringer-Mannheim Medal, Australian Society for Biochemistry and Molecular Biology Inc.
• 1997 - Gottschalk Medal, Australian Academy of Science
• 2006 - Research Australia Medical Media Award

Career:

• 1985-1987 - Genentech Inc, South San Francisco, California, USA
• 1987-1998 - ZMBH (Centre for Molecular Biology), University of Heidelberg
• 1988-1991 - Pacific Biotechnology Limited, Rushcutters Bay, Sydney
• 1991-2004 - Garvan Institute of Medical Research (NHMRC Senior, Principal and Senior Principal Research Fellow)
• 1998-2004 - Founder and Managing Director, PsyGene Pty Ltd
• 1999-2004 - Director, Neurobiology Research Program, Garvan Institute of Medical Research
• 1996-2000 - Associate Professor, School of Medicine and Department of Biotechnology, University of New South Wales
• 2000-present - Professor, Faculty of Medicine, University of New South Wales
• 2004-present - Executive Director and Chief Executive Officer, NeuRA

Facilities profile

Current appointments

Chief Investigator, Genetic Repositories Australia

Bio

Related content

Research grant

• NHMRC Project. Biological characterisation of the familial neurodegeneration opiod receptor sigma 1 (OPRS1) gene.
• NHMRC/ARC Ageing Well Ageing Productively Research Program. Gene-environment interaction in healthy brain ageing and age related neurodegeneration.
• NHMRC Project Grant. The biological role of the cadherin gene FAT in bipolar disorder susceptibility.
• NARSAD Young Investigator Award. Identification of variants causing altered expression of susceptibility gene in bipolar disorder.
• NHMRC Project Grant. Cloning and characterisation of a bipolar susceptibility gene on chromosome 15q.

Research group

• Schofield Group

Research paper

• Differences in regional brain atrophy in genetic forms of Alzheimer's disease.
• Pedigree with frontotemporal lobar degeneration--motor neuron disease and Tar DNA binding protein-43 positive neuropathology: genetic linkage to chromosome 9
• PARK2 mutations and clinical features in a Chinese population with early-onset Parkinson's disease
• Variable phenotype of Alzheimer's disease with spastic paraparesis
• Glycogen synthase kinase-3beta and tau genes interact in Alzheimer's disease
• Mutations in progranulin explain atypical phenotypes with variants in MAPT
• GSK3B polymorphisms alter transcription and splicing in Parkinson's Disease
• A Western Australian kindred with Dutch cerebral amyloid angiopathy
• Tau haplotypes regulate transcription and are associated with Parkinson's disease.
• Presenilin-1 Mutation (L271V) Results in Altered Exon 8 Splicing and Alzheimer's Disease with Non-cored Plaques and No Neuritic Dystrophy.
• Variable phenotype of Alzheimer's disease with spastic paraparesis.
• Two Novel (M233T AND R278T) Presenilin-1 Mutations In Early-onset Alzheimer's-Disease Pedigrees and Preliminary evidence for Association of Presenilin-1 Mutations with a Novel Phenotype.
• Mutations in the tau gene that cause an increase in three repeat tau and frontotemporal dementia